Brought to you by 
TomoTherapy completes $187mm IPO
06 Jun 2007
Executive Summary
TomoTherapy (image-guided cancer treatment) has completed its initial public offering. The company sold 10.6mm common shares at $19 apiece for net proceeds of $187mm; its had originally filed to sell 10.2mm shares priced between $15-17.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
TomoTherapy completes $187mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice